Glenmark Specialty SA received final approval from the US Food and Drug Administration for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation. The product has been determined by the ...

ELMWOOD PARK, N.J., March 4, 2026 /PRNewswire/ -- Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Fluticasone Propionate ...

Commercially available valved holding chambers used in pediatric inhalation therapy are often considered interchangeable. A randomized trial showed that young children with acute wheezing had better ...

ACCIDENTAL AS THE FIRE REMAINS UNDER INVESTIGATION. ALSO IN ANDERSON COUNTY, THE CORONER IS INVESTIGATING AFTER A MAN DIED FOLLOWING A BACKYARD FIRE. WE’RE TOLD RESPONDERS WERE CALLED TO GRANTHAM ROAD ...

Please provide your email address to receive an email when new articles are posted on . Many parents believe children will outgrow wheeze without seeing a specialist. Many patients also underestimate ...

When Elena Saenz, RRT, NPS, a 30-year respiratory therapist (RT), recently observed a physician approach one of her staff members, who had been charting notes on a difficult-to-treat pediatric patient ...

PRAGUE, Oct. 23, 2025 /PRNewswire/ -- European innovation leader H₂ Global Group today announced that its subsidiary H₂ Medical Technologies has received official approval from The State Institute for ...

Hyperbaric oxygen therapy (HBOT) used in conjunction with corticosteroids aids outcomes for sudden sensorineural hearing loss (SSNHL), according to a study published online in Clinical Otolaryngology.

As many people are shifting from commercial cleaners to products they already have on hand, hydrogen peroxide is among the many ingredients used as "green" cleaners. It also has several possible uses ...

Aptar Digital Health’s Respiratory Disease Management Platform provides real-time usage tracking and encourages medication adherence through reminders and educational resources. The Food and Drug ...

Statistically Significant 35% Placebo-Adjusted Reduction from Baseline in Pulmonary Vascular Resistance for the Primary Endpoint (p<0.001) 35.5 Meter Placebo-Adjusted Improvement in Six-Minute Walk ...